By successfully encapsulating a vaccine into a spider silk microparticle, Swiss and German researchers have discovered a novel technique that will help fight cancer and certain infectious diseases.
To fight cancer, researchers increasingly use vaccines that stimulate the immune system to identify and destroy tumour cells. However, the desired immune response is is not always guaranteed. In order to strengthen the efficacy of vaccines on the immune system – and in particular on T lymphocytes, specialized in the detection of cancer cells – researchers from the universities of Geneva (UNIGE), Freiburg (UNIFR), Munich, and Bayreuth, in collaboration with the German company AMSilk, have developed spider silk microcapsules capable of delivering the vaccine directly to the heart of immune cells. This process, published in the journal Biomaterials, could also be applied to preventive vaccines to protect against infectious diseases, and constitutes an important step towards vaccines that are stable, easy to use, and resistant to the most extreme storage conditions.
Our immune system is largely based on two types of cells: B lymphocytes, which produce the antibodies needed to defend against various infections, and T lymphocytes. In the case of cancer and certain infectious diseases such as tuberculosis, T lymphocytes need to be stimulated. However, their activation mechanism is more complex than that of B lymphocytes: to trigger a response, it is necessary to use a peptide, a small piece of protein which, if injected alone, is rapidly degraded by the body even before reaching its target.
“To develop immunotherapeutic drugs effective against cancer, it is essential to generate a significant response of T lymphocytes,» says Professor Carole Bourquin, a specialist in antitumor immunotherapies at the faculties of medicine and science of the UNIGE, who directed this work. “As the current vaccines have only limited action on T-cells, it is crucial to develop other vaccination procedures to overcome this issue.”
A virtually indestructible capsule
Scientists used synthetic spider silk biopolymers—a lightweight, biocompatible, non-toxic material that is highly resistant to degradation from light and heat. “We recreated this special silk in the lab to insert a peptide with vaccine properties,» explains Thomas Scheibel, a world specialist of spider silk from the University of Bayreuth who participated in the study. “The resulting protein chains are then salted out to form injectable microparticles.”
Silk microparticles form a transport capsule that protects the vaccine peptide from rapid degradation in the body, and delivers the peptide to the center of the lymph node cells, thereby considerably increasing T lymphocyte immune responses. “Our study has proved the validity of our technique”, reveals Carole Bourquin. “We have demonstrated the effectiveness of a new vaccination strategy that is extremely stable, easy to manufacture and easily customizable.”
Towards a new vaccine model
The synthetic silk biopolymer particles demonstrate a high resistance to heat, withstanding over 100°C for several hours without damage. In theory, this process would make it possible to develop vaccines that do not require adjuvants and cold chains. An undeniable advantage, especially in developing countries where one of the great difficulties is the preservation of vaccines. One of the limitations of this process, however, is the size of the microparticles: while the concept is in principle applicable to any peptide, which are all small enough to be incorporated into silk proteins, further research is needed to see if it is also possible to incorporate the larger antigens used in standard vaccines, especially against viral diseases.
When science imitates nature
“More and more, scientists are trying to imitate nature in what it does best”, adds Scheibel. “This approach even has a name: bioinspiration, which is exactly what we have done here.” The properties of spider silk make it a particularly interesting product: biocompatible, solid, thin, biodegradable, resistant to extreme conditions and even antibacterial, one can imagine multiple applications, including wound dressings or sutures.
Learn more: A new kind of vaccine based on spider silk
The Latest on: Vaccine delivery
[google_news title=”” keyword=”vaccine delivery” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Vaccine delivery
- Future vaccines could be delivered by a gentle puff of airon March 27, 2023 at 6:02 pm
which is the current delivery method. The findings are due to be presented at a meeting of the American Chemical Society. The post Future vaccines could be delivered by a gentle puff of air appeared ...
- COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancyon March 27, 2023 at 3:34 pm
Researchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.
- ‘Point and shoot’: Air ‘gun’ could deliver vaccines and other medication painlesslyon March 27, 2023 at 8:19 am
Could a puff of air one day replace the needle in delivering medicines and vaccines? These scientists are working on it. View on euronews ...
- Vaccine Delivery Devices Market Size, Growth Opportunities, Industry Analysis by Share, Application and Top Key Players 2023 to 2031on March 27, 2023 at 5:19 am
Biotech and pharmaceutical firms, in collaboration with governments throughout the world, are developing a plan to address supply chain difficulties in vaccine distribution and the development of ...
- A puff of air could deliver your next vaccineon March 27, 2023 at 2:00 am
Nobody likes needles, but they're necessary for delivering many vaccines and biologics into the body. But what if those could be puffed through the skin instead, with just a little pressure, like ...
- Vaccines Delivery Market 2023 | Increasing Global Driving Industry Growth till 2030 | 84 Pages Reporton March 27, 2023 at 1:53 am
The Vaccines Delivery Market (2023-2030) Updated Latest Research Report is divided into various types [Biological ...
- Delivery Matters: In Early Studies, DPX Technology Allows Vaccines to Persist When Cancer Pushes Backon March 26, 2023 at 7:00 am
Based on promising results, the biotech IMV has moved into phase 2b trials with a cancer vaccine composed of survivin epitopes that uses the company’s proprietary delivery system to elicit persistent ...
- Researchers develop a universal oral COVID-19 vaccine that prevents severe illness in hamsterson March 22, 2023 at 5:53 am
A UCLA-led team has developed an inexpensive, universal oral COVID-19 vaccine that prevented severe respiratory illness and weight loss when tested in hamsters, which are naturally susceptible to SARS ...
- Moderna eyes ~$130 price tag for COVID vaccine shot in US - reporton March 21, 2023 at 2:43 am
Hoge's comments come ahead of a Congressional hearing headed by Democratic Senator Bernie Sanders, who had previously requested Moderna to suspend raising the price of the vaccine due to the ...
via Bing News